Matthias Feige studied Biochemistry at the Swiss Federal Institute of Technology (ETHZ) and the Technische Universität München (TUM), where he obtained his PhD in biochemistry. As a postdoctoral fellow at the St. Jude Children’s Research Hospital in Memphis, TN, USA, he expanded his research towards cell biology. In 2014 Matthias Feige was appointed as a Rudolf Mößbauer Tenure Track Professor at the TUM-IAS and now heads the laboratory for Cellular Protein Biochemistry at the TUM Department of Chemistry (cv).
Stephanie Müller obtained her BSc in Biomedical Science at the Philipps-Universität Marburg and pursued her Master studies at the Albert-Ludwigs-Universität Freiburg, Universität Basel and Université de Strasbourg. During her Master thesis at NEB, she worked in the group of Peter Weigele, PhD on novel phage enzymes. Stephanie joined the lab in May 2015 to work on the folding and quality control of IL12 cytokines.
Susanne Meier studied Biochemistry at the Technische Universität München (TUM). During her Master thesis under the guidance of Prof. Aymelt Itzen, she worked on the characterization of a newly identified Legionella pneumophila effector. In June 2015 Susanne started her PhD in the CPB lab, focusing on the folding and quality control of IL12 cytokines.
Yonatan Mideksa obtained his BSc in Biochemistry and Cell Biology at the Jacobs University Bremen and continued his MSc studies at the Åbo Akademi University in Turku, Finland. During his Master thesis Yonatan worked in the laboratory of Prof. Daniel Abankwa on the signaling mechanisms of small GTPases. In January 2016 Yonatan joined the CPB lab to study the folding of IL12 cytokines.
Joao Coelho studied Biochemistry at the University of Lisbon in Portugal. As a Fundacao Amadeu Dias fellow and during his Master thesis, both under the supervision of Prof. Carlos Farinha, Joao has worked on the biogenesis and disease mechanisms of CFTR. In January 2016 Joao joined the CPB lab to study quality control mechanisms of integral membrane proteins.
Nicolas Blömeke obtained his BSc in Biotechnology at the Hamburg University of Applied Sciences and continued his studies in Biochemistry at the TUM. During his Master thesis in the group of Stefan Jentsch at the Max Planck Institute of Biochemistry Nicolas was working on repair mechanisms of DNA-protein crosslinks. In October 2016 Nicolas joined the CPB lab to study quality control mechanisms of integral membrane proteins.
Anna Miesl obtained her training at the TUM Department of Chemistry in fields from macromolecular chemistry to protein biochemistry. In July 2017 Anna joined the CPB lab, managing and supporting our research on interleukins and integral membrane proteins.
Karen Hildenbrand studied Biochemistry in Ulm, where she obtained her BSc. She continued her studies in Turku, Finland, and Munich. Karen performed her Master thesis in the CPB lab, working on the biogenesis of IL35 as an inhibitory IL12 family member. From February 2017 on Karen continues her studies on IL12 cytokines in our lab as a PhD student.
Sina Bohnacker obtained her Bachelor in Molecular Biotechnology at the TUM. Subsequently Sina continued her studies in Biochemistry at the TUM including a research stay at the Fondazione Edmund Mach in Italy. In 2018 Sina finished her Master thesis in the CPB lab, analyzing the structure and folding of IL23. Since January 2019, Sina is a PhD student in the CPB lab and the lab of Julia Esser-von Bieren (ZAUM), working on the biological functions of new immunomodulatory proteins.
Dinah Kaylani studies Biochemistry at the Technische Universität München (TUM). In her Bachelor thesis at the Werner Siemens Lehrstuhl für synthethische Biotechnologie (Prof. Dr. Thomas Brück) Dinah focused on targeted mutagenesis of enzymes for industrial terpene synthesis. After research work at terraplasma medical GmbH and the DZIF, Dinah joined the CPB lab in March 2019 and currently works on membrane protein quality control.
Isabel Aschenbrenner obtained her Bachelor in Biochemistry at the TUM, performing her Bachelor thesis in the CPB lab on the biogenesis of IL23. Subsequently, Isabel continued her studies in Biochemistry at the TUM including a research stay at Concordia University in Montreal. In her Master thesis in the CPB lab Isabel analyzed the biogenesis, engineering and biological functions of IL27. In her PhD, which she began in April 2019, Isabel now works on IL12 and IL23 biogenesis, engineering and potential pharmacological targeting.
Kevin Meighen-Berger studies Biochemistry at the TU Munich. For his Bachelor thesis, he worked in Hendrik Dietz's lab on new DNA Origami structures at the TUM Physics Department. After further research work at the Institute of Medical Engineering, TUM, and terraplasma medical GmbH, Kevin started his Master thesis in the CPB lab in April 2019. His research focusses on a better understanding of membrane protein quality control by Calnexin.